retatrutide triple agonist obesity π¨ Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent and type 2 diabetes. π Mean body weight change at 80 weeks: β¬οΈ triple-hormone-receptor agonist retatrutide for obesity
Pay in 4 interest-free payments of $6.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 21 - Aug 26
























